Prostate Cancer Treatment in Cuba: Comprehensive Oncology Care

Prostate Cancer Treatment in Cuba

Cuba provides comprehensive prostate cancer treatment through its national oncology network, offering the full spectrum of conventional therapies including surgery (radical prostatectomy), radiation therapy (external beam and brachytherapy), hormonal (androgen deprivation) therapy, and chemotherapy for advanced disease. Cuban oncology centers follow international treatment guidelines and treat both local and international patients.

Prostate cancer is one of the most common cancers in men worldwide. Cuba has significant experience in prostate cancer management, with screening programs (PSA testing) and standardized treatment protocols integrated into the national health system. The country's biotechnology sector, led by the Center of Molecular Immunology (CIM), also conducts research into immunotherapeutic approaches that may benefit prostate cancer patients.

For international patients, SMC Salud coordinates comprehensive prostate cancer programs including medical review, treatment planning, and coordinated care at Havana's oncology facilities.

Conventional Treatment Options

Cuba's prostate cancer treatment follows standard international protocols:

• Active surveillance — For low-risk, localized prostate cancer, monitoring with regular PSA tests, biopsies, and MRI rather than immediate treatment. • Radical prostatectomy — Surgical removal of the prostate gland, performed by experienced urological surgeons. May be open or laparoscopic depending on the facility and case. • Radiation therapy — External beam radiation therapy (EBRT) or brachytherapy (radioactive seed implantation) for localized prostate cancer. • Hormonal therapy (androgen deprivation therapy) — Reducing testosterone levels to slow cancer growth, using medications (LHRH agonists/antagonists) or surgical castration (orchiectomy). • Chemotherapy — For castration-resistant prostate cancer (docetaxel, cabazitaxel). • Bone-targeted therapy — For metastatic disease spreading to bones (denosumab, bisphosphonates, radium-223).

Treatment plans are individualized based on cancer stage, Gleason score, PSA level, patient age, overall health, and treatment goals. The choice between surgery, radiation, and active surveillance depends on risk stratification and shared decision-making between the patient and medical team.

Cuban Biotechnology & Immunotherapy Research

Cuba's Center of Molecular Immunology (CIM) has contributed to cancer immunotherapy research relevant to prostate cancer:

• CIMAher (nimotuzumab) — An anti-EGFR monoclonal antibody. EGFR is expressed in some prostate cancers, and research has explored whether anti-EGFR therapy may have a role in prostate cancer treatment, particularly in castration-resistant disease. This research is in the clinical trial phase.

• Cancer vaccine research — Cuba's expertise in therapeutic cancer vaccines (CIMAvax-EGF for lung cancer) has prompted research into similar approaches for other cancers. While no prostate cancer vaccine has been approved, the biotechnology platform could potentially be applied to prostate-specific antigens.

• Heberprot-P platform — While Heberprot-P is used for diabetic foot ulcers, the underlying growth factor technology demonstrates Cuba's capability in developing targeted biological therapies.

It is important to note that immunotherapy for prostate cancer in Cuba is in the research phase. Conventional treatment (surgery, radiation, hormonal therapy) remains the standard of care. Experimental immunotherapy may be available in clinical trial contexts for eligible patients, but this is not guaranteed and should not replace evidence-based treatment.

International Patient Journey

For international patients seeking prostate cancer treatment in Cuba, SMC Salud coordinates:

• Medical review — Submission and review of pathology reports (biopsy with Gleason score), PSA history, imaging (MRI, bone scan, CT), and prior treatment records. • Treatment proposal — Individualized treatment plan with transparent cost breakdown. • Travel coordination — Medical visa, flights, accommodation, airport reception. • Treatment at Havana's oncology facilities — Multidisciplinary care coordinated by experienced urology and oncology teams. • Interpreter services — Professional medical interpreters in multiple languages. • Comprehensive medical report — For the home-country urologist/oncologist. • Telemedicine follow-up — Continued consultation after returning home.

The multidisciplinary team includes urologists, medical oncologists, radiation oncologists, and radiologists, ensuring comprehensive evaluation and treatment planning for each patient's specific case.